Could less be more? new trial tests lower antibiotic dose for pneumonia
NCT ID NCT07537413
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two doses of the antibiotic ceftriaxone for adults hospitalized with pneumonia (but not in the ICU). The goal is to see if a 1-gram daily dose works just as well as a 2-gram daily dose while causing fewer side effects. About 430 participants will be followed to track recovery and safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMUNITY-ACQUIRED PNEUMONIA (CAP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
-
University of Maryland Medical Center - Midtown Campus
Baltimore, Maryland, 21201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New antibiotic lefamulin takes on Drug-Resistant pneumonia
- Could your Child's cough help diagnose asthma or pneumonia?
- Herbal formula NRICM102 tested as pneumonia Add-On treatment
- Pneumonia drug trial aims to protect arteries from hidden damage
- Promising pneumonia therapy trial pulled before it began
- Which steroid works best for severe pneumonia? major trial aims to find out